Citations (88)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Kyuhyeon Ahn, Hyeongjoon Ji, Hye-Eun Kim, Hyejoung Cho, Qiaochu Sun, Shuhan Shi, Yuzhu He, Byung-Gook Kim & Okjoon Kim. (2020) Raphanus sativus L. seed extracts induce apoptosis and reduce migration of oral squamous cell carcinoma KB and KBCD133+cells by downregulation of β-catenin. Nutrition and Cancer 72:8, pages 1378-1389.
Read now
Read now
Wenbo Zheng, Chunzhao Yang, Ling Qiu, Xiaochuang Feng, Kai Sun & Haijun Deng. (2020) Transcriptional information underlying the generation of CSCs and the construction of a nine-mRNA signature to improve prognosis prediction in colorectal cancer. Cancer Biology & Therapy 21:8, pages 688-697.
Read now
Read now
Amir Barzegar Behrooz, Amir Syahir & Syahida Ahmad. (2019) CD133: beyond a cancer stem cell biomarker. Journal of Drug Targeting 27:3, pages 257-269.
Read now
Read now
Yao Wang, Meixia Chen, Zhiqiang Wu, Chuan Tong, Hanren Dai, Yelei Guo, Yang Liu, Jianhua Huang, Haiyan Lv, Can Luo, Kai-chao Feng, Qing-ming Yang, Xiao-lei Li & Weidong Han. (2018) CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial. OncoImmunology 7:7.
Read now
Read now
Benedetta Bussolati, Federica Collino & Giovanni Camussi. (2012) CD133+ cells as a therapeutic target for kidney diseases. Expert Opinion on Therapeutic Targets 16:2, pages 157-165.
Read now
Read now
Chia-Ying Lin, Lin Wang, Khoi Than, Frank La Marca & Paul Park. (2010) Cancer stem cell markers: what is their diagnostic value?. Expert Opinion on Medical Diagnostics 4:6, pages 473-481.
Read now
Read now
Articles from other publishers (82)
Riya Thapa, Obaid Afzal, Muhammad Afzal, Gaurav Gupta, Asif Ahmad Bhat, Waleed Hassan almalki, Imran Kazmi, Sami I. Alzarea, Shakir Saleem, Poonam Arora, Sachin Kumar Singh & Kamal Dua. (2024) From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression. Pathology - Research and Practice 253, pages 154959.
Crossref
Crossref
V. Aarthi & Indranil Chattopadhyay. 2024. Cancer Stem Cells and Signaling Pathways. Cancer Stem Cells and Signaling Pathways
119
133
.
Nadine Soliman, Ashish Saharia, Maen Abdelrahim & Ashton A. Connor. (2023) Molecular profiling in the management of hepatocellular carcinoma. Current Opinion in Organ Transplantation.
Crossref
Crossref
Andarz Fazlollahpour Naghibi, Danyal Daneshdoust, Seyed Reza Taha, Sara Abedi, Pardis Abdali Dehdezi, Mahdieh Shariat Zadeh, Fatemeh Dokoohaki & Mehdi Soleymani-Goloujeh. (2023) Role of cancer stem cell-derived extracellular vesicles in cancer progression and metastasis. Pathology - Research and Practice 247, pages 154558.
Crossref
Crossref
Jacob Petersburg, Daniel A. Vallera & Carston R. Wagner. (2023) Eradication of Heterogeneous Tumors by T Cells Targeted with Combination Bispecific Chemically Self-assembled Nanorings. Molecular Cancer Therapeutics 22:3, pages 371-380.
Crossref
Crossref
Mariele Montanari, Michele Guescini, Ozan Gundogdu, Francesca Luchetti, Paola Lanuti, Caterina Ciacci, Sabrina Burattini, Raffaella Campana, Claudio Ortolani, Stefano Papa & Barbara Canonico. (2022) Extracellular Vesicles from Campylobacter jejuni CDT-Treated Caco-2 Cells Inhibit Proliferation of Tumour Intestinal Caco-2 Cells and Myeloid U937 Cells: Detailing the Global Cell Response for Potential Application in Anti-Tumour Strategies. International Journal of Molecular Sciences 24:1, pages 487.
Crossref
Crossref
Kun Liu, Liping Jiang, Yulin Shi, Baiyang Liu, Yaomei He, Qiushuo Shen, Xiulin Jiang, Zhi Nie, Jun Pu, Cuiping Yang & Yongbin Chen. (2022) Hypoxia-induced GLT8D1 promotes glioma stem cell maintenance by inhibiting CD133 degradation through N-linked glycosylation. Cell Death & Differentiation 29:9, pages 1834-1849.
Crossref
Crossref
Dannel Yeo, Caroline Giardina, Payal Saxena & John E.J. Rasko. (2022) The next wave of cellular immunotherapies in pancreatic cancer. Molecular Therapy - Oncolytics 24, pages 561-576.
Crossref
Crossref
Jiaojiao Guo & Qi Tang. (2021) Recent updates on chimeric antigen receptor T cell therapy for hepatocellular carcinoma. Cancer Gene Therapy 28:10-11, pages 1075-1087.
Crossref
Crossref
Dong Pan, Yarong Du, Rong Li, Aihua Shen, Xiaodong Liu, Chuanyuan Li & Burong Hu. (2021) miR-29b-3p Increases Radiosensitivity in Stemness Cancer Cells via Modulating Oncogenes Axis. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Jianshu Wei, Yelei Guo, Yao Wang, Zhiqiang Wu, Jian Bo, Bin Zhang, Jun Zhu & Weidong Han. (2020) Clinical development of CAR T cell therapy in China: 2020 update. Cellular & Molecular Immunology 18:4, pages 792-804.
Crossref
Crossref
Binbin Zheng-Lin & Eileen M. O’Reilly. 2021.
Karim Dadashi Noshahr, Fahimeh Shamsi, Peter Valtchev, Parviz Kokhaei, Maral Hemati, Mohammad Reza Akbari Eidgahi & Ali Khaleghian. (2020) Optimization of post-insertion method to conjugate Doxil with anti-CD133 monoclonal antibodies: Investigating the specific binding and cytotoxicity to colorectal cancer cells in vitro. Saudi Pharmaceutical Journal 28:11, pages 1392-1401.
Crossref
Crossref
Salvador Gomez, Allan Tsung & Zhiwei Hu. (2020) Current Targets and Bioconjugation Strategies in Photodynamic Diagnosis and Therapy of Cancer. Molecules 25:21, pages 4964.
Crossref
Crossref
Yuna Jo, Laraib Amir Ali, Ju A Shim, Byung Ha Lee & Changwan Hong. (2020) Innovative CAR-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield. Cancers 12:8, pages 2087.
Crossref
Crossref
Rowa Y. Alhabbab. (2020) Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells. Frontiers in Genetics 11.
Crossref
Crossref
Subbroto Kumar Saha, S. M. Riazul Islam, Kyung-Sup Kwak, Md. Shahedur Rahman & Ssang-Goo Cho. (2019) PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis. Cancer Gene Therapy 27:3-4, pages 147-167.
Crossref
Crossref
L.C. Cutmore, N.F. Brown, D. Raj, S. Chauduri, P. Wang, J. Maher, Y. Wang, N.R. Lemoine & J.F. Marshall. (2020) Pancreatic Cancer UK Grand Challenge: Developments and challenges for effective CAR T cell therapy for pancreatic ductal adenocarcinoma. Pancreatology 20:3, pages 394-408.
Crossref
Crossref
Monish Ram Makena, Alok Ranjan, Vani Thirumala & Arubala P Reddy. (2020) Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:4, pages 165339.
Crossref
Crossref
Stephen J. Bagley & Donald M. O’Rourke. (2020) Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions. Pharmacology & Therapeutics 205, pages 107419.
Crossref
Crossref
Mahdi Abbasian, Elham Mousavi, Zahra Arab‐Bafrani & Amirhossein Sahebkar. (2018) The most reliable surface marker for the identification of colorectal cancer stem‐like cells: A systematic review and meta‐analysis. Journal of Cellular Physiology 234:6, pages 8192-8202.
Crossref
Crossref
Mohamad Sonbol, Daniel Ahn & Tanios Bekaii-Saab. (2019) Therapeutic Targeting Strategies of Cancer Stem Cells in Gastrointestinal Malignancies. Biomedicines 7:1, pages 17.
Crossref
Crossref
Lyudmila OunpuuLaura TruuIgor ShevchukVladimir ChekulayevAleksandr KlepininAndre KoitKersti TeppMarju PuurandEgle Rebane-KlemmTuuli Käämbre. (2018) Comparative analysis of the bioenergetics of human adenocarcinoma Caco-2 cell line and postoperative tissue samples from colorectal cancer patients. Biochemistry and Cell Biology 96:6, pages 808-817.
Crossref
Crossref
Teresa Bernadette Steinbichler, József Dudás, Sergej Skvortsov, Ute Ganswindt, Herbert Riechelmann & Ira-Ida Skvortsova. (2018) Therapy resistance mediated by cancer stem cells. Seminars in Cancer Biology 53, pages 156-167.
Crossref
Crossref
Stephan Marquardt, Manish Solanki, Alf Spitschak, Julio Vera & Brigitte M. Pützer. (2018) Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis. Seminars in Cancer Biology 53, pages 90-109.
Crossref
Crossref
Somi Kim, Chang Yun Cho, Doohyung Lee, Dae-Geun Song, Hye-Jin Kim, Jae Woo Jung, Ji Eon Kim, Dasomi Park, Haesong Lee, Hyejin Um, Jinsoo Park, Yoonjeong Choi, Yoomin Kim, Seo Hee Nam & Jung Weon Lee. (2018) CD133-induced TM4SF5 expression promotes sphere growth via recruitment and blocking of protein tyrosine phosphatase receptor type F (PTPRF). Cancer Letters 438, pages 219-231.
Crossref
Crossref
Zhiwei Hu. (2018) Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases. Antibodies 7:1, pages 8.
Crossref
Crossref
Lili Zhao, Jun Li, Manli Liu, Hongrun Zhou, Hong Zou, Yutao Wei, Kunming Sun, Ganxiong Li, Shugang Li & Lijuan Pang. (2017) The clinicopathological parameters significance of CD133 and Nestin in epithelial ovarian cancer: a meta-analysis. Future Oncology 13:28, pages 2555-2570.
Crossref
Crossref
Brigitte M. Pützer, Manish Solanki & Ottmar Herchenröder. (2017) Advances in cancer stem cell targeting: How to strike the evil at its root. Advanced Drug Delivery Reviews 120, pages 89-107.
Crossref
Crossref
Zhixin Liu, Xuechen Dai, Tianci Wang, Chengcheng Zhang, Wenjun Zhang, Wei Zhang, Qi Zhang, Kailang Wu, Fang Liu, Yingle Liu & Jianguo Wu. (2017) Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells. Cancer Letters 400, pages 149-160.
Crossref
Crossref
Olumide Gbolahan, Amer Zeidan, Maximilian Stahl, Mohammad Abu Zaid, Sherif Farag, Sophie Paczesny & Heiko Konig. (2017) Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment. International Journal of Molecular Sciences 18:8, pages 1660.
Crossref
Crossref
Konduru S Sastry, Aouatef Ismail Chouchane, Ena Wang, George Kulik, Francesco M Marincola & Lotfi Chouchane. (2017) Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling. Cell Death & Disease 8:6, pages e2844-e2844.
Crossref
Crossref
Zhiwei Hu, Jie Xu, Jijun Cheng, Elizabeth McMichael, Lianbo Yu & William E. CarsonIIIIII. (2016) Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer. Oncotarget 8:1, pages 1481-1494.
Crossref
Crossref
Joerg U. Schmohl, Martin Felices, Deborah Todhunter, Elizabeth Taras, Jeffrey S. Miller & Daniel A. Vallera. (2016) Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linker. Oncotarget 7:45, pages 73830-73844.
Crossref
Crossref
Kevin F. Ginn, Ben Fangman, Kaoru Terai, Amanda Wise, Daniel Ziazadeh, Kushal Shah, Robyn Gartrell, Brandon Ricke, Kyle Kimura, Sharad Mathur, Emma Borrego-Diaz & Faris Farassati. (2016) RalA is overactivated in medulloblastoma. Journal of Neuro-Oncology 130:1, pages 99-110.
Crossref
Crossref
Jörg Schmohl & Daniel Vallera. (2016) CD133, Selectively Targeting the Root of Cancer. Toxins 8:6, pages 165.
Crossref
Crossref
Luis Tume, Karen Paco, Roberto Ubidia-Incio & Jeel Moya. (2016) CD133 in breast cancer cells and in breast cancer stem cells as another target for immunotherapy. Gaceta Mexicana de Oncología 15:1, pages 22-30.
Crossref
Crossref
Laura Lasagni, Elena Lazzeri, Anna Peired & Paola Romagnani. 2016. Kidney Development, Disease, Repair and Regeneration. Kidney Development, Disease, Repair and Regeneration
395
406
.
Ying-Jhen Su, Wei-Hsin Lin, Yi-Wen Chang, Kuo-Chen Wei, Chi-Lung Liang, Shin-Cheh Chen & Jia-Lin Lee. (2015) Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties. Oncotarget 6:35, pages 38029-38045.
Crossref
Crossref
Bethany A. Kerr, Ranko Miocinovic, Armine K. Smith, Xiaoxia Z. West, Katherine E. Watts, Amanda W. Alzayed, Joseph C. Klink, Maria C. Mir, Tiffany Sturey, Donna E. Hansel, Warren D. Heston, Andrew J. Stephenson, Eric A. Klein & Tatiana V. Byzova. (2014) CD117+ cells in the circulation are predictive of advanced prostate cancer. Oncotarget 6:3, pages 1889-1897.
Crossref
Crossref
Yun Ding, Cosma D. Dellisanti, Mi Hee Ko, Cynthia Czajkowski & Luigi Puglielli. (2014) The Endoplasmic Reticulum-based Acetyltransferases, ATase1 and ATase2, Associate with the Oligosaccharyltransferase to Acetylate Correctly Folded Polypeptides. Journal of Biological Chemistry 289:46, pages 32044-32055.
Crossref
Crossref
Qiang Yang, Ting Zhang, Chunling Wang, Jiao Jiao, Jing Li & Yihui Deng. (2014) Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells. European Journal of Pharmaceutics and Biopharmaceutics 88:3, pages 737-745.
Crossref
Crossref
Nate N. Waldron, Sanford H. Barsky, Phillip R. Dougherty & Daniel A. Vallera. (2013) A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma. Targeted Oncology 9:3, pages 239-249.
Crossref
Crossref
Luis Fernando Tume Farfán. (2014) La inmunoterapia en la búsqueda de antígenos contra las células madre del cáncer. Inmunología 33:3, pages 96-109.
Crossref
Crossref
Zhou Bin, Zhang Guangbo, Ge Yan, Zhou Huan, Lv Desheng & Zhang Xueguang. (2014) Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients. Journal of Surgical Research 188:2, pages 396-403.
Crossref
Crossref
Anthony B. Mak, Mariana Pehar, Allison M.L. Nixon, Rashida A. Williams, Andrea C. Uetrecht, Luigi Puglielli & Jason Moffat. (2014) Post-Translational Regulation of CD133 by ATase1/ATase2-Mediated Lysine Acetylation. Journal of Molecular Biology 426:11, pages 2175-2182.
Crossref
Crossref
Anthony B. Mak, Caroline Schnegg, Chiou-Yan Lai, Subrata Ghosh, Moon Hee Yang, Jason Moffat & Mei-Yu Hsu. (2014) CD133-Targeted Niche-Dependent Therapy in Cancer. The American Journal of Pathology 184:5, pages 1256-1262.
Crossref
Crossref
José David Gómez Rangel. 2014. Stem Cells in Cancer: Should We Believe or Not?. Stem Cells in Cancer: Should We Believe or Not?
191
202
.
Darko Katalinic, Ranka Stern-Padovan, Irena Ivanac, Ivan Aleric, Damir Tentor, Nora Nikolac, Fedor Santek, Antonio Juretic & Stjepko Plestina. (2013) Symptomatic cardiac metastases of breast cancer 27 years after mastectomy: a case report with literature review - pathophysiology of molecular mechanisms and metastatic pathways, clinical aspects, diagnostic procedures and treatment modalities. World Journal of Surgical Oncology 11:1.
Crossref
Crossref
Jianhua Huang, Chonghui Li, Yao Wang, Haiyan Lv, Yelei Guo, Hanren Dai, Max S. Wicha, Alfred E. Chang & Qiao Li. (2013) Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133high cancer stem cells in vitro and in vivo. Clinical Immunology 149:1, pages 156-168.
Crossref
Crossref
M Ying, G Liu, H Shimada, W Ding, W A May, Q He, G B Adams & L Wu. (2012) Human osteosarcoma CD49f−CD133+ cells: impaired in osteogenic fate while gain of tumorigenicity. Oncogene 32:36, pages 4252-4263.
Crossref
Crossref
A. B. Mak & J. Moffat. (2013) RNA interference screens to uncover membrane protein biology. Briefings in Functional Genomics 12:5, pages 422-429.
Crossref
Crossref
Heather Hardin, Celina Montemayor-Garcia & Ricardo V. Lloyd. (2013) Thyroid cancer stem-like cells and epithelial-mesenchymal transition in thyroid cancers. Human Pathology 44:9, pages 1707-1713.
Crossref
Crossref
Kuan-Min Fang, Tzu-Chien Lin, Ti-Chun Chan, Shi-Zhang Ma, Bo-Cheng Tzou, Wen-Ruei Chang, Jun-Jen Liu, Shih-Hwa Chiou, Chung-Shi Yang & Shun-Fen Tzeng. (2013) Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions. Glia 61:9, pages 1402-1417.
Crossref
Crossref
Monica Bostad, Kristian Berg, Anders Høgset, Ellen Skarpen, Harald Stenmark & Pål K. Selbo. (2013) Photochemical internalization (PCI) of immunotoxins targeting CD133 is specific and highly potent at femtomolar levels in cells with cancer stem cell properties. Journal of Controlled Release 168:3, pages 317-326.
Crossref
Crossref
Edwin E. Reyes, Stefan K. Kunovac, Ryan Duggan, Steven Kregel & Donald J. Vander Griend. (2013) Growth kinetics of CD133-positive prostate cancer cells. The Prostate 73:7, pages 724-733.
Crossref
Crossref
A Pohl, A El-Khoueiry, D Yang, W Zhang, G Lurje, Y Ning, T Winder, S Hu-Lieskoven, S Iqbal, K D Danenberg, M Kahn, J-L Teo, J Shriki, J Stebbing & H-J Lenz. (2012) Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy. The Pharmacogenomics Journal 13:2, pages 173-180.
Crossref
Crossref
Sarah Shigdar, Liang Qiao, Shu-Feng Zhou, Dongxi Xiang, Tao Wang, Yong Li, Lee Yong Lim, Lingxue Kong, Lianhong Li & Wei Duan. (2013) RNA aptamers targeting cancer stem cell marker CD133. Cancer Letters 330:1, pages 84-95.
Crossref
Crossref
Ricardo V. Lloyd, Heather Hardin, Celina Montemayor-Garcia, Fabio Rotondo, Luis V Syro, Eva Horvath & Kalman Kovacs. (2013) Stem Cells and Cancer Stem-Like Cells in Endocrine Tissues. Endocrine Pathology 24:1, pages 1-10.
Crossref
Crossref
Philipp Grosse‐Gehling, Christine A Fargeas, Claudia Dittfeld, Yvette Garbe, Malcolm R Alison, Denis Corbeil & Leoni A Kunz‐Schughart. (2012) CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. The Journal of Pathology 229:3, pages 355-378.
Crossref
Crossref
Nate Waldron & Daniel Vallera. (2013) An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells. Antibodies 2:4, pages 82-92.
Crossref
Crossref
Benedetta Bussolati & Giovanni Camussi. 2013. Prominin-1 (CD133): New Insights on Stem & Cancer Stem Cell Biology. Prominin-1 (CD133): New Insights on Stem & Cancer Stem Cell Biology
113
123
.
Han Hong Lee, Kyung Jin Seo, Chang Hyeok An, Jeong Soo Kim & Hae Myung Jeon. (2012) CD133 expression is correlated with chemoresistance and early recurrence of gastric cancer. Journal of Surgical Oncology 106:8, pages 999-1004.
Crossref
Crossref
Hiroaki Fujimori, Mima Shikanai, Hirobumi Teraoka, Mitsuko Masutani & Ken-ichi Yoshioka. (2012) Induction of Cancerous Stem Cells during Embryonic Stem Cell Differentiation. Journal of Biological Chemistry 287:44, pages 36777-36791.
Crossref
Crossref
Anthony B. Mak, Allison M.L. Nixon, Saranya Kittanakom, Jocelyn M. Stewart, Ginny I. Chen, Jasna Curak, Anne-Claude Gingras, Ralph Mazitschek, Benjamin G. Neel, Igor Stagljar & Jason Moffat. (2012) Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation. Cell Reports 2:4, pages 951-963.
Crossref
Crossref
Daniela Burgos-Ojeda, Bo R. Rueda & Ronald J. Buckanovich. (2012) Ovarian cancer stem cell markers: Prognostic and therapeutic implications. Cancer Letters 322:1, pages 1-7.
Crossref
Crossref
Anthony B. Mak & Jason Moffat. (2012) A versatile lentiviral expression system to identify mammalian protein–protein interactions. Methods 57:4, pages 409-416.
Crossref
Crossref
Anthony B. Mak, Allison M.L. Nixon & Jason Moffat. (2012)
The Mixed Lineage Leukemia (MLL) Fusion–Associated Gene
AF4
Promotes CD133 Transcription
. Cancer Research 72:8, pages 1929-1934.
Crossref
Crossref
E. Bourseau-Guilmain, J. Béjaud, A. Griveau, N. Lautram, F. Hindré, M. Weyland, J.P. Benoit & E. Garcion. (2012) Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133. International Journal of Pharmaceutics 423:1, pages 93-101.
Crossref
Crossref
Maurizio Di BonitoFrancesca CollinaMonica CantileRosalba CamerlingoMargherita CerroneLaura MarraGiuseppina LiguoriGiuseppe PirozziGerardo Botti. (2012) Aberrant Expression of Cancer Stem Cells Marker Prominin-1 in Low-Grade Tubulobular Breast Carcinoma: A Correlative Study between qRT-PCR, Flow-Cytometric and Immunohistochemistry Analysis. Journal of Breast Cancer 15:1, pages 15.
Crossref
Crossref
Michael Jäger, Alexandra Schoberth, Peter Ruf, Juergen Hess, Michael Hennig, Barbara Schmalfeldt, Pauline Wimberger, Michael Ströhlein, Bettina Theissen, Markus M. Heiss & Horst Lindhofer. (2012) Immunomonitoring Results of a Phase II/III Study of Malignant Ascites Patients Treated with the Trifunctional Antibody Catumaxomab (Anti-EpCAM × Anti-CD3). Cancer Research 72:1, pages 24-32.
Crossref
Crossref
Qiuzhen Liu, Marianna Sabatino, David F. Stroncek, Ping Jin, Francesco M. Marincola & Ena Wang. 2012. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma
227
241
.
Anthony B. Mak, Kim M. Blakely, Rashida A. Williams, Pier-Andrée Penttilä, Andrey I. Shukalyuk, Khan T. Osman, Dahlia Kasimer, Troy Ketela & Jason Moffat. (2011) CD133 Protein N-Glycosylation Processing Contributes to Cell Surface Recognition of the Primitive Cell Marker AC133 Epitope. Journal of Biological Chemistry 286:47, pages 41046-41056.
Crossref
Crossref
Erika Bourseau-Guilmain, Audrey Griveau, Jean-Pierre Benoit & Emmanuel Garcion. (2011) The Importance of the Stem Cell Marker Prominin-1/CD133 in the Uptake of Transferrin and in Iron Metabolism in Human Colon Cancer Caco-2 Cells. PLoS ONE 6:9, pages e25515.
Crossref
Crossref
Kun Yang, Xin-Zu Chen, Bo Zhang, Chen Yang, Hai-Ning Chen, Zhi-Xin Chen, Zong-Guang Zhou, Jia-Ping Chen & Jian-Kun Hu. (2018) Is CD133 a Biomarker for Cancer Stem Cells of Colorectal Cancer and Brain Tumors? A Meta-Analysis. The International Journal of Biological Markers 26:3, pages 173-180.
Crossref
Crossref
Zhilong Ai, Hongtao Pan, Tao Suo, Chentao Lv, Yueqi Wang, Saixiong Tong & Houbao Liu. (2011) Arsenic oxide targets stem cell marker CD133/prominin-1 in gallbladder carcinoma. Cancer Letters.
Crossref
Crossref
Giuseppe Pirozzi, Virginia Tirino, Rosa Camerlingo, Renato Franco, Aantonello La Rocca, Eleonora Liguori, Nicola Martucci, Francesca Paino, Nicola Normanno & Gaetano Rocco. (2011) Epithelial to Mesenchymal Transition by TGFβ-1 Induction Increases Stemness Characteristics in Primary Non Small Cell Lung Cancer Cell Line. PLoS ONE 6:6, pages e21548.
Crossref
Crossref
Timo Gaiser, Jordi Camps, Sandra Meinhardt, Danny Wangsa, Quang Tri Nguyen, Sudhir Varma, Claudia Dittfeld, Leoni A. Kunz-Schughart, Ralf Kemmerling, Maria R. Becker, Kerstin Heselmeyer-Haddad & Thomas Ried. (2011) Genome and Transcriptome Profiles of CD133-Positive Colorectal Cancer Cells. The American Journal of Pathology 178:4, pages 1478-1488.
Crossref
Crossref
Mario Schubert, Nicolás Herbert, Isabel Taubert, Dan Ran, Rahul Singh, Volker Eckstein, Mario Vitacolonna, Anthony D. Ho & Margot Zöller. (2011) Differential survival of AML subpopulations in NOD/SCID mice. Experimental Hematology 39:2, pages 250-263.e4.
Crossref
Crossref
G. S. Patel, T. Kiuchi, K. Lawler, E. Ofo, G. O. Fruhwirth, M. Kelleher, E. Shamil, R. Zhang, P. R. Selvin, G. Santis, J. Spicer, N. Woodman, C. E. Gillett, P. R. Barber, B. Vojnovic, G. Kéri, T. Schaeffter, V. Goh, M. J. O'Doherty, P. A. Ellis & T. Ng. (2011) The challenges of integrating molecular imaging into the optimization of cancer therapy. Integrative Biology 3:6, pages 603.
Crossref
Crossref
Chizuko Tsurumi, Norbert Esser, Elke Firat, Simone Gaedicke, Marie Follo, Martin Behe, Ursula Elsässer-Beile, Anca-Ligia Grosu, Ralph Graeser & Gabriele Niedermann. (2010) Non-Invasive In Vivo Imaging of Tumor-Associated CD133/Prominin. PLoS ONE 5:12, pages e15605.
Crossref
Crossref
Po Zhao, Yazhuo Li & Yali Lu. (2010) Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma. BMC Cancer 10:1.
Crossref
Crossref